本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trevi Therapeutics Inc.

10.53
+0.03000.29%
成交量:150.41万
成交额:1,602.51万
市值:12.82亿
市盈率:-25.34
高:10.90
开:10.48
低:10.37
收:10.50
52周最高:11.11
52周最低:2.36
股本:1.22亿
流通股本:9,063.42万
量比:1.21
换手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-0.4155
每股收益(LYR):-0.4698
净资产收益率:-35.74%
总资产收益率:-22.83%
市净率:6.46
市盈率(LYR):-22.41

数据加载中...

2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/04/14

重要事件披露

8-K - Current report
2023/04/11

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report